Site Search

Share

X

Search Results

New Survey: 1 in 10 Cancer Patients Has Been Impacted by Nation’s Drug Shortages with Significant Delays to Cancer Care

... the current issue as well as prevent future crises.”  In addition to the impact of the current drug shortages, respondents were asked if biomarker testing, an increasingly important tool in cancer care, had changed the course of their treatment. An overwhelming majority of respondents (77%) who have had biomarker testing agreed that the results gave their provider valuable information that led to better treatment, with the same number (77%) of ...

Register for Delaware Cancer Action Day

Help Expand Biomarker Testing in Delaware  Tuesday, May 13, 2025 | 10:00 AM – 2:30 PM At Cancer Action Day, you will meet in with lawmakers and push for expanding insurance coverage for biomarker testing, so more patients can access the personalized, life-saving treatments they need. No advocacy experience? No worries. We'll start ...

New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes

... February 22, 2024 – A new paper released today in the Journal of Clinical Oncology    finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and ... from them.” ACS CAN is working to improve access to PGx testing through its state advocacy work to expand insurance coverage of comprehensive biomarker testing, which includes PGx testing. Biomarker testing is a critical step toward accessing precision medicine, including targeted therapies; however, not all patients who could benefit ...

Governor Signs Legislation to Increase Access to Precision Treatment for Cancer Patients

... IL – “Last week, Gov. JB Pritzker signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing.  HB1779 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments. Dubbed ‘the right treatment, to the right patient, at the right ...

Illinois Elected Officials Increase Access to Care for Cancer Patients

... passed legislation that will improve access to care for cancer patients by making out-of-pocket costs more predictable and expand coverage for biomarker testing.  HB1745 will make prescription drug expenses more predictable by requiring health insurance carriers to offer more health plans with flat ... to their local pharmacy and being shocked by their monthly prescription costs. Separately, HB1799 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments. Dubbed ‘the right treatment, to the right patient, at the right ...

Louisiana Elected Officials Increase Access to Care for Cancer Patients

... passed legislation that will improve access to care for cancer patients through co-pay accumulator legislation and the expansion of coverage for biomarker testing.  “Many cancer patients have difficulty affording the cost of their prescription drugs. In a co-pay accumulator program, co-pay ... that all payments made by patients, directly or on their behalf, count toward their overall out-of-pocket maximum or deductible.   “The biomarker testing legislation will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine ...

Wichita Falls Resident Ensures His Mother’s Legacy Fighting for Texans with Cancer Lives on

... back up and continued her fight.”   Today, Franklin is among a group of Texans leading the charge for Texas lawmakers to ensure access to biomarker testing – which allows doctors to better understand an individual patient’s cancer and prescribe targeted therapies. Frankin credits biomarker testing and subsequent targeted treatment with granting him many more years with his mother; unfortunately, many Texans are unable to ...

It is Time to Reduce the Burden of Cancer on Buckeyes

... to prioritize passing legislation to ease the burden of cancer on Buckeyes.  “ACS CAN calls on the legislature to increase access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role ...

Steps Governor Hochul Can Take to Make New York a Leader in Health Equity

... a bold step in health policy and greater accessibility to precision medicine technologies. ACS CAN proposes that New York improve access to biomarker testing—a technology that enables oncologists to provide the right treatment for the right patient at the right time. Allowing oncologists to ... treatment with precision medicine can lead to better outcomes. Right now, not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Many health insurance plans in New York, including Medicaid, may not cover the most appropriate biomarker ...

Pennsylvania Cancer Action Day 2024

... there are 4 personal stories that relate to the 4 asks, remember they have to be short. Here is an example: Introductions + purpose of meeting Biomarker story + ask Paid Family and Medical Leave + ask Medical debt + ask Budget (prevention programs) + ask Conclusion w/reiterating the 4 ... on our asks. If you are curious to see what is in those packets, take a look at these factsheets: 2024 Legislative Priorities PA Facts + Figures Biomarker Testing Factsheet Paid Family and Medical Leave Factsheet Medical Debt Factsheet PA Breast and Cervical Cancer Early Detection Program Factsheet PA ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy